New 6-Month shot shows promise in taming prostate cancer
NCT ID NCT05590793
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 26 times
Summary
This study tested a single injection of triptorelin pamoate that lasts 6 months in 195 Chinese men with advanced or metastatic prostate cancer. The goal was to lower testosterone to castrate levels, which helps control cancer growth. The treatment was effective and safe, offering a convenient option for long-term disease management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Hebei University
Baoding, China
-
Beijing Hospital
Beijing, China
-
Chongqing University Cancer Hospital
Chongqing, China
-
Deyang People's Hospital
Deyang, China
-
Fudan University Shang Hai Cancer Center
Shanghai, China
-
Guizhou Provincial People's Hospital
Guiyang, China
-
Henan Cancer Hospital
Zhengzhou, China
-
Hunan Cancer Hospital
Changsha, China
-
Liaoning Cancer Hospital & Institute
Shenyang, China
-
Nanjing Drum Tower Hospital
Nanjing, China
-
Ningbo First Hospital
Ningbo, China
-
Northern Jiangsu People's Hospital
Yangzhou, China
-
Peking University First Hospital
Beijing, China
-
Peking University People's Hospital
Beijing, China
-
Peking University Shenzhen Hospital
Shenzhen, China
-
Qilu Hospital of Shandong University
Jinan, China
-
Shandong Provincial Hospital
Jinan, China
-
Shanghai Fifth People's Hospital
Shanghai, China
-
Shanghai Tongji Hospital
Shanghai, China
-
Subei People's Hospital
Yangzhou, China
-
Suining Central Hospital
Suining, China
-
Sun Yat-Sen University Cancer Center
Guangzhou, China
-
The Affiliated Hospital of Guizhou Medical University
Guiyang, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
-
The First Affiliated Hospital of Wannan Medical College
Wuhu, China
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
-
The First Hospital of China Medical University
Shenyang, China
-
The Second Affiliated Hospital of Soochow University
Suzhou, China
-
The Second Affiliated Hospital of Wannan Medical College
Wuhu, China
-
Tianjin Cancer Hospital
Tianjin, China
-
West China Hospital of Sichuan University
Chengdu, China
-
Wuxi People's Hospital
Wuxi, China
-
Yantai Yuhuangding Hospital
Yantai, China
-
Zhongda Hospital Southeast University
Nanjing, China
-
Zigong First People's Hospital
Zigong, China
Conditions
Explore the condition pages connected to this study.